Investors & Media Financials & Filings Investor Relations Overview Corporate Governance Press Releases & Statements Events & Presentations SEC Filings Annuals and Proxies Investor FAQs Financials & Filings Quarterly Results Stock Information Analyst Coverage Email Alerts Subscription Notice of Pendency of Settlement of Action Financials & Filings Show all 2023 Third Quarter Sage Therapeutics Announces Third Quarter 2023 Financial Results and Highlights Pipeline and Business Progress Form 10-Q Annual Reports Title View 2021 Annual Report 2021 Annual Report 1.8 MB 2020 Annual Report 2020 Annual Report 2.6 MB Proxy Statements Title View 2023 Proxy Statement 2023 Proxy Statement 2.7 MB Form 10-K Filing date View Mar 17, 2015 View HTML 0001193125-15-094364.pdf 0001193125-15-094364.xls Form 10-Q Filing date View Aug 14, 2014 0001193125-14-310086.pdf 0001193125-14-310086.rtf 0001193125-14-310086.xls EX-101.INS - XBRL INSTANCE DOCUMENT View HTML Nov 13, 2014 0001193125-14-410228.pdf 0001193125-14-410228.rtf 0001193125-14-410228.xls EX-101.INS - XBRL INSTANCE DOCUMENT View HTML
Financials & Filings Show all 2023 Third Quarter Sage Therapeutics Announces Third Quarter 2023 Financial Results and Highlights Pipeline and Business Progress Form 10-Q Annual Reports Title View 2021 Annual Report 2021 Annual Report 1.8 MB 2020 Annual Report 2020 Annual Report 2.6 MB Proxy Statements Title View 2023 Proxy Statement 2023 Proxy Statement 2.7 MB Form 10-K Filing date View Mar 17, 2015 View HTML 0001193125-15-094364.pdf 0001193125-15-094364.xls Form 10-Q Filing date View Aug 14, 2014 0001193125-14-310086.pdf 0001193125-14-310086.rtf 0001193125-14-310086.xls EX-101.INS - XBRL INSTANCE DOCUMENT View HTML Nov 13, 2014 0001193125-14-410228.pdf 0001193125-14-410228.rtf 0001193125-14-410228.xls EX-101.INS - XBRL INSTANCE DOCUMENT View HTML
